Sentinel lymph node biopsy with micrometastases in breast cancer: Histological data and surgical implications. About a series of 201 axillary dissections after peroperative sentinel node identification;Ganglions sentinelles avec micrométastases dans le cancer du sein: Données histologiques et implications chirurgicales. À propos d'une série de 201 curages axillaires après identification peropératoire des ganglions sentinelles

Bulletin du Cancer

Volumn 90, Issue 5, 2003, Pages 459-465

  Marin, Cristi ^a   Mathelin, Carole ^a   Neuville, Agnès ^a   Mertz, Luc ^a   Constantinesco, André ^a   Chenard, Marie Pierre ^a   Bellocq, Jean Pierre ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Axillary dissection; Breast cancer; Micrometastases; Sentinel lymph node

Indexed keywords

TRACER;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; METASTASIS; MULTIPLE CANCER; SENTINEL LYMPH NODE BIOPSY; THICKNESS; TUMOR CLASSIFICATION; TUMOR VOLUME; AXILLA; BREAST TUMOR; CANCER STAGING; CARCINOMA; CLINICAL TRIAL; FEMALE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

AXILLA; BREAST NEOPLASMS; CARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 0041705338     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchick A, Giuliano AE. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999; 229: 536-41.
2. Doting MHE, Jansen L, Nieweg OE, Piers DA, Tiebosch ATMG, Koops HS, et al. Lymphatic mapping with intralesional tracer administration in breast carcinoma patients. Cancer 2000; 88: 2546-52.
3. Bedrosian I, Reynolds C, Mick R, Callans LS, Grant CS, Donohue JH, et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 2000; 88: 2540-5.
4. Weaver DL, Krag DN, Ashikaga T, Harlow SP, O'Connell M. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 2000; 88: 1099-107.
5. Czerniecki BJ, Scheff AM, Callans LS, Spitz FR, Bedrosian I, Conant EF, et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma. Cancer 1999; 85: 1098-103.
6. Reynolds C, Mick R, Donohue JH, Grant CS, Farley DR, Callans LS, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999; 17: 1720-6.
7. Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC, et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000; 89: 574-81.
8. Kamath VJ, Giuliano R, Dauway EL, Cantor A, Berman C, Ku NN, et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 2001; 136: 688-92.
9. Silverberg SG. Sentinel node processing: recommendations for pathologists. Am J Surg Pathol 2002; 26: 383-5.
10. de Mascarel I, MacGrogan G, Picot V, Mathoulin-Pelissier S. Prognostic significance of immunohistochemically detected breast cancer node metastases in 218 patients. Br J Cancer 2002; 87: 70-4.
11. International Ludwig Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 1990; 335: 1565-8.
12. Nasser IA, Lee AKC, Bosari S, Saganich R, Heatley G, Silverman M. Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 1993; 24: 950-7.
13. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node mictometastases from breast carcinoma. Reviewing the dilemma. Cancer 1997; 80: 1188-97.
14. Trojani M, de Mascarel I, Bonichon F, Coindre JM, Delsol G. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 1987; 55: 303-6.
15. Cote RJ, Peterson HE Chaiwun B, Gelber RD, Goldhirsch A, Castiglione-Gertsch M, et al., for the International Breast Cancer Study Group. Role of immunohistochimical detection of lymph-node metastases in management of breast cancer. Lancet 1999; 354: 896-900.
16. Ollila DW, Brennan MB, Giuliano AE. Therapeutic effect of sentinel lymphadenectomy in T1 breast cancers. Arch Surg 1998; 133: 647-51.
17. Hill AD, Tran KN, Akhurst T, Yeung H, Yeh SD, Rosen PP, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999; 229: 528-35.
18. Cserni G. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol 1999; 52: 922-4.
19. Teng S, Dupont E, McCann C, Wang J, Bolano M, Durand K, et al. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer? Am Surg 2000; 66: 574-8.
20. Rahusen FD, Pijpers R, Van Diest PJ, Bleichrodt RP, Torrenga H, Meijer S. The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer. Surgery 2000; 128: 6-12.
21. Abdessalam SF, Zervos EE, Prasad M, Farrar WB, Yee LD, Walker MJ, et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 2001; 182: 316-20.
22. Chua B, Ung O, Taylor R, Bilous M, Salisbury E, Boyages J. Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma. Cancer 2001; 92: 1769-74.
23. Viale G, Maiorano E, Mazzarol G, Zurrida S, Galimberti V, Luini A, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer 2001; 92: 1378-84.
24. Weiser MR, Montgomery LL, Tan LK, Susnik B, Leung DY, Borgen PI, Cody HS 3rd. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Ontol 2001; 8: 145-9.
25. Canavese G, Gipponi M, Catturich A, Vecchio C, Tomei D, Nicolo G, et al. Technical issues and pathologic implications of sentinel lymph node biopsy in early-stage breast cancer patients. J Surg Ontol 2001; 77: 81-8.
26. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998; 186: 275-83.
27. Turner RR, Ollila DW, Stern S, Giuliano AE. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 1999; 23: 263-7.
28. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226: 271-8.
29. Dowlatshahi K, Fan M, Bloom KJ, Spitz DJ, Patel S, Snider HC. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer 1999; 86: 990-6.
30. McIntosh SA, Going JJ, Soukop M, Purushotham AD, Cooke TG. Therapeutic implications of the sentinel lymph node in breast cancer. Lancet 1999; 354: 570.
31. Offodile R, Hoh C, Barsky SH, Nelson SD, Elashoff R, Eilber FR, et al. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran. Cancer 1998; 82: 1704-8.
32. Van Diest PJ, Torrenga H, Borgstein PJ, Pijpers R, Bleichrodt RP, Rahusen FD, et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 1999; 35: 14-8.
33. Turner RR, Hansen NM, Stern SL, Giuliano AE. Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol 1999; 112: 627-34.
34. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, et al. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000; 18: 2553-9.
35. Yared MA, Middleton LP, Smith TL, Kim HW, Ross MI, Hunt KK, Sahin AA. Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol 2002; 26: 377-82.
36. Fréneaux P, Nos C, Vincent-Salomon A, Genin P, Sigal-Zafrani B, Al Ghuzlan A, et al. Histological detection of minimal metasratic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice. Mod Pathol 2002; 15: 641-6.
37. Torrenga H, Rahusen FD, Meijer S, Borgstein PJ, Van Diest PJ. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 2001; 54: 550-2.
38. Snider H, Dowlatshahi K, Fan M, Bridget WM, Rayudu G, Oleske D. Sentinel node biopsy in the staging of breast cancer. Am J Surg 1998; 176: 305-10.
39. Jannink I, Fan M, Nagy S, Rayudu G, Dowlatshahi K. Serial sectioning of sentinel nodes in patients with breast cancer: a pilot study. Ann Surg Oncol 1998; 5: 310-4.
40. Dowlatshahi K, Fan M, Anderson JM, Bloom KJ. Occult. metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol 2001; 8: 675-81.
41. Chu KU, Turner RR, Hansen NM, Brennan MB, Giuliano AE. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol 1999; 6: 756-61.
42. Cserni G. Sentinel lymph-node biopsy-based prediction of further breast cancer metastases in the axilla. Eur J Surg Oncol 2001; 27: 532-8.
43. Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1,262 invasive ductal breast carcinomas. Caner 1989; 64: 1914-21.
44. Mertz L, Mathelin C, Marin C, Gairard B, Chenard MP, Brettes JP, et al. Injection sous-aréolaire de sulfocholoïdes technétiés pour l'identificarion des ganglions sentinelles dans les cancers du sein invasifs à foyers multiples. Bull Cancer 1999; 86: 939-45.
45. Hermanek P, Hutter RVP, Sobin LH, Wittekind C. Classification of isolated tumor cells and micrometastasis. Cancer 1999; 86: 2668-73.